Close Menu

NEW YORK (360Dx) – Ortho Clinical Diagnostics announced today that it has signed an international distribution and copromotion agreement covering 14 assays with Thermo Fisher Scientific.

Under the terms of the deal, the companies will deliver assays for monitoring therapeutics, immunosuppressants, and drugs of abuse to hospitals, hospital networks, and labs that use Ortho's Vitros 4600 chemistry system and Vitros 5600 integrated system. The assays will initially be launched in North America, Europe, Africa, and the Middle East.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.